F
Filterlex Medical
Biotech & Life Sciences · Yokneam Ilit, Israel · Founded 2015
Filterlex created the CAPTIS® intra-aortic EPD to deflect, capture, and remove embolic particles during TAVI. This new EPD offers full-body protection by trapping and eliminating embolic debris MoreLess
Developer of an embolic protection device designed to help patients with complications during catheter-based structural heart procedures. The company's device uses next-generation technology to meet the need of current product limitations and weaknesses and is securely positioned in the aorta to provide full-body embolic protection by deflecting, capturing, and removing embolic particles, enabling physicians to reduce the risk of stroke and other complications during catheter-based structural heart procedures. Keywords: Pharmaceuticals and Biotechnology, Cardiovascular Tools, Embolic Protection Device, Embolic Protection System, Embolic Protection Technology, Stroke Cure, Surgical Technology.
Talent graph
Filterlex Medical's talent
Source: Dealroom Talent Intelligence.
Investors
3 investors on Filterlex Medical's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where Filterlex Medical has talent and traffic
team presence
Market sentiment
What the market is saying about Filterlex Medical
An AI-synthesized read of the highest-engagement posts about Filterlex Medical on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Filterlex Medical on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.